Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD
- 7 June 2010
- journal article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 8 (6), 1431-1433
- https://doi.org/10.1111/j.1538-7836.2010.03869.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor functionJournal of Thrombosis and Haemostasis, 2009
- Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factorBlood, 2009
- von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)1Haemophilia, 2008
- von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagenJournal of Thrombosis and Haemostasis, 2006
- A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD)Journal of Thrombosis and Haemostasis, 2006
- Mapping the Collagen-binding Site in the von Willebrand Factor-A3 DomainOnline Journal of Public Health Informatics, 2003
- von Willebrand Factor Collagen-Binding (Activity) Assay in the Diagnosis of von Willebrand Disease: A 15-Year JourneySeminars in Thrombosis and Hemostasis, 2002
- Identification of the Collagen-binding Site of the von Willebrand Factor A3-domainOnline Journal of Public Health Informatics, 2001
- Interaction of the von Willebrand Factor (vWF) with CollagenOnline Journal of Public Health Informatics, 1995
- An elisa test for the binding of von willebrand antigen to collagenThrombosis Research, 1986